Nuclear medicine has made significant strides in the field of oncology, particularly through the development of molecular probes and targeted radiopharmaceuticals. This progress has transformed cancer diagnosis and treatment, allowing for more accurate imaging and specialized therapeutic options that target specific cancer biomarkers and molecular pathways. The advent of new imaging agents, therapeutic isotopes, and cutting-edge delivery methods continues to advance precision oncology, offering enhanced personalization and effectiveness in cancer management.
This Research Topic aims to explore the development and validation of novel molecular probes and drug targets in nuclear medicine for enhanced cancer care. It seeks to facilitate the translation of laboratory innovations into clinical settings, emphasizing interdisciplinary collaboration to fuel advances in oncology.
To gather further insights into the rigorous processes of creation and clinical application of these advanced tools, we welcome articles covering, but not limited to, the following themes:
o Development of innovative molecular probes
o Design of new radiopharmaceuticals
o Preclinical and clinical validation of nuclear medicine applications
o Discovery of novel cancer-specific targets
o Advances in imaging and therapeutic technologies
o Translational studies linking lab research to clinical practice
Nuclear medicine has made significant strides in the field of oncology, particularly through the development of molecular probes and targeted radiopharmaceuticals. This progress has transformed cancer diagnosis and treatment, allowing for more accurate imaging and specialized therapeutic options that target specific cancer biomarkers and molecular pathways. The advent of new imaging agents, therapeutic isotopes, and cutting-edge delivery methods continues to advance precision oncology, offering enhanced personalization and effectiveness in cancer management.
This Research Topic aims to explore the development and validation of novel molecular probes and drug targets in nuclear medicine for enhanced cancer care. It seeks to facilitate the translation of laboratory innovations into clinical settings, emphasizing interdisciplinary collaboration to fuel advances in oncology.
To gather further insights into the rigorous processes of creation and clinical application of these advanced tools, we welcome articles covering, but not limited to, the following themes:
o Development of innovative molecular probes
o Design of new radiopharmaceuticals
o Preclinical and clinical validation of nuclear medicine applications
o Discovery of novel cancer-specific targets
o Advances in imaging and therapeutic technologies
o Translational studies linking lab research to clinical practice